Marielle JARJAT – IPMC

Recherche

Intranet

Thème

Aurore THOMAZEAU

Biographie pas encore disponible.

Actualités

Inserm : les chercheurs de l'IPMC accueillent les malades

Le 14 juin 2025, l’IPMC a accueilli plusieurs associations de patients pour une matinée d’échanges autour de la douleur, de […]

Publications

Delhaye S, Jarjat M, Boulksibat A, Sanchez C, Tempio A, Turtoi A, Giorgi M, Lacas-Gervais S, Baj G, Rovere C, Trezza V, Pellegrini M, Maurin T, Lalli E, Bardoni B, Defects in AMPAR trafficking and microglia activation underlie socio-cognitive deficits associated to decreased expression of phosphodiesterase 2 a., Neurobiol Dis 2024 Feb; 191(): 106393.

Schiavi S, Carbone E, Melancia F, di Masi A, Jarjat M, Brau F, Cardarelli S, Giorgi M, Bardoni B, Trezza V, Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder., Transl Psychiatry 2022 Mar; 12(1): 119.

Carmen Ruggiero, Nelly Durand, Marielle Jarjat, Jacques Barhanin, Elena J Ghirardello, Michael R G Dack, Graham R Williams, J H Duncan Bassett, Enzo Lalli, The secreted protein augurin is a novel modulator of canonical Wnt signalling involved in osteoblast differentiation, Clinical and Translational Discovery, 2022, 2 (3), pp.e113. ⟨10.1002/ctd2.113⟩.

Ruggiero C, Altieri B, Arnold E, Siqueiros-Marquez L, Doghman-Bouguerra M, Detomas M, Durand N, Jarjat M, Kurlbaum M, Chatonnet F, Deutschbein T, Clapp C, Lalli E, Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function., Clin Transl Med 2021 Nov; 11(11): e630.

Castagnola S, Cazareth J, Lebrigand K, Jarjat M, Magnone V, Delhaye S, Brau F, Bardoni B, Maurin T, Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brain., Genome Res 2020 Nov; 30(11): 1633-1642.

Maurin T, Melancia F, Jarjat M, Castro L, Costa L, Delhaye S, Khayachi A, Castagnola S, Mota E, Di Giorgio A, Servadio M, Drozd M, Poupon G, Schiavi S, Sardone L, Azoulay S, Ciranna L, Martin S, Vincent P, Trezza V, Bardoni B, Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome., Cereb Cortex 2019 Jul; 29(8): 3241-3252.

Drozd M, Delhaye S, Maurin T, Castagnola S, Grossi M, Brau F, Jarjat M, Willemsen R, Capovilla M, Hukema RK, Lalli E, Bardoni B, Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS., Mol Ther Nucleic Acids 2019 Dec; 18(): 546-553.

Maurin T, Lebrigand K, Castagnola S, Paquet A, Jarjat M, Popa A, Grossi M, Rage F, Bardoni B, HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein., Nucleic Acids Res 2018 Jul; 46(12): 6344-6355.

Castagnola S, Delhaye S, Folci A, Paquet A, Brau F, Duprat F, Jarjat M, Grossi M, Béal M, Martin S, Mantegazza M, Bardoni B, Maurin T, New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons., Front Mol Neurosci 2018 ; 11(): 342.

Khalfallah O, Jarjat M, Davidovic L, Nottet N, Cestèle S, Mantegazza M, Bardoni B, Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis., Stem Cells 2017 Feb; 35(2): 374-385.

Maurin T, Melko M, Abekhoukh S, Khalfallah O, Davidovic L, Jarjat M, D'Antoni S, Catania MV, Moine H, Bechara E, Bardoni B, The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum., Nucleic Acids Res 2015 Sep; 43(17): 8540-50.

Latre de Late P, El Wakil A, Jarjat M, de Krijger RR, Heckert LL, Naquet P, Lalli E, Vanin-1 inactivation antagonizes the development of adrenocortical neoplasia in Sf-1 transgenic mice., Endocrinology 2014 Jul; 155(7): 2349-54.